These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

131 related items for PubMed ID: 12660689

  • 1. Tissue plasminogen activator for ischemic stroke: unintended consequences.
    J Emerg Nurs; 2003 Apr; 29(2):96-7. PubMed ID: 12660689
    [No Abstract] [Full Text] [Related]

  • 2. The smoking-thrombolysis paradox and acute ischemic stroke.
    Fisher M.
    Neurology; 2006 Feb 14; 66(3):458; author reply 458. PubMed ID: 16476964
    [No Abstract] [Full Text] [Related]

  • 3. An 89-year-old woman with angioedema during t-PA infusion for acute ischemic stroke.
    Jahnke HK.
    J Emerg Nurs; 2003 Apr 14; 29(2):142-4. PubMed ID: 12660697
    [No Abstract] [Full Text] [Related]

  • 4. Stroke thrombolysis: is tissue plasminogen activator a defibrillator for the brain?
    Buchan AM, Feasby TE.
    CMAJ; 2000 Jan 11; 162(1):47-8. PubMed ID: 11216198
    [No Abstract] [Full Text] [Related]

  • 5. Symptomatic intracerebral hemorrhage among eligible warfarin-treated patients receiving intravenous tissue plasminogen activator for acute ischemic stroke.
    Prabhakaran S, Rivolta J, Vieira JR, Rincon F, Stillman J, Marshall RS, Chong JY.
    Arch Neurol; 2010 May 11; 67(5):559-63. PubMed ID: 20212195
    [Abstract] [Full Text] [Related]

  • 6. Acute ischemic stroke: Not a moment to lose.
    Miller J, Mink J.
    Nursing; 2009 May 11; 39(5):37-42; quiz 42-3. PubMed ID: 19395934
    [Abstract] [Full Text] [Related]

  • 7. Ischaemic stroke: decide rapidly.
    Prescrire Int; 2015 Sep 11; 24(163):221. PubMed ID: 26417638
    [Abstract] [Full Text] [Related]

  • 8. Antiplatelet therapy and the risk of intracranial hemorrhage after intravenous tissue plasminogen activator therapy for acute ischemic stroke.
    Hallevi H, Grotta JC.
    Arch Neurol; 2008 May 11; 65(5):575-6. PubMed ID: 18474730
    [No Abstract] [Full Text] [Related]

  • 9. [Fatal massive hemoptysis during thrombolysis of acute ischemic stroke].
    de la Torre-Laviana FJ, Redondo L, Antunez-Infante A, Alvarez-Marquez E.
    Rev Neurol; 2008 May 11; 43(8):510-1. PubMed ID: 17033985
    [No Abstract] [Full Text] [Related]

  • 10. Hemorrhagic transformation after acute ischemic stroke thrombolysis treatment: navigating the landscape of hemostasis genetic risk factors.
    Bagoly Z.
    J Thromb Haemost; 2024 Apr 11; 22(4):919-921. PubMed ID: 38521577
    [No Abstract] [Full Text] [Related]

  • 11. Hemorrhagic conversion after alteplase administration in a patient with vasculitis and acute ischemic stroke.
    Gilbert BW, Dhakal L, Lacy A, Huffman JB.
    Am J Health Syst Pharm; 2019 Feb 01; 76(4):211-213. PubMed ID: 30689698
    [Abstract] [Full Text] [Related]

  • 12. Review of tissue plasminogen activator, ischemic stroke, and potential legal issues.
    Liang BA, Lew R, Zivin JA.
    Arch Neurol; 2008 Nov 01; 65(11):1429-33. PubMed ID: 19001160
    [Abstract] [Full Text] [Related]

  • 13. Local intra-arterial thrombolysis with urokinase for acute ischemic stroke before and after the approval of intravenous tissue plasminogen activator treatment in Taiwan.
    Yang FC, Lin CC, Hsueh CJ, Lee JT, Hsu CH, Lee KW, Peng GS.
    Ann Vasc Surg; 2010 Nov 01; 24(8):1117-24. PubMed ID: 21035704
    [Abstract] [Full Text] [Related]

  • 14. Subtherapeutic warfarin is not associated with increased hemorrhage rates in ischemic strokes treated with tissue plasminogen activator.
    Vergouwen MD, Casaubon LK, Swartz RH, Fang J, Stamplecoski M, Kapral MK, Silver FL, Investigators of the Registry of the Canadian Stroke Network.
    Stroke; 2011 Apr 01; 42(4):1041-5. PubMed ID: 21350204
    [Abstract] [Full Text] [Related]

  • 15. The safety of intravenous thrombolysis for ischemic stroke in patients with pre-existing cerebral aneurysms: a case series and review of the literature.
    Edwards NJ, Kamel H, Josephson SA.
    Stroke; 2012 Feb 01; 43(2):412-6. PubMed ID: 22156701
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Hemorrhagic transformation after fibrinolytic therapy with tissue plasminogen activator in a rat thromboembolic model of stroke.
    Kano T, Katayama Y, Tejima E, Lo EH.
    Brain Res; 2000 Jan 31; 854(1-2):245-8. PubMed ID: 10784130
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.